Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
Impact in
- Rheumatology 438
- Surgery 124
Classified as
- Authors
- Per Magne UelandHelga Refsum
- Journal
- PubMed
In The Last Decade
doi.org/w72192601 →Countries where authors are citing Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
This map shows the geographic impact of Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. more than expected).
Fields of papers citing Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
This network shows the impact of Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy..
About Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
This paper, published in 1989, received 520 indexed citations . Written by Per Magne Ueland and Helga Refsum covering the research area of Rheumatology. It is primarily cited by scholars working on Rheumatology (438 citations), Surgery (124 citations), Clinical Biochemistry (82 citations), Hematology (52 citations) and Physiology (49 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w72192601.